• Citer

The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease

par Brown, Janet;McCloskey, Eugene V.;Dewar, Joanna;Body, Jean-Jacques ;Cameron, David A;Harnett, Adrian;Ruutu, M.;Purohit, Omprakash Prakash;Tähtelä, Rita;Coleman, Robert
Référence Calcified tissue international, 81, 5, page (341-351)
Publication Publié, 2007-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease
Auteur:	Brown, Janet; McCloskey, Eugene V.; Dewar, Joanna; Body, Jean-Jacques; Cameron, David A; Harnett, Adrian; Ruutu, M.; Purohit, Omprakash Prakash; Tähtelä, Rita; Coleman, Robert
Informations sur la publication:	Calcified tissue international, 81, 5, page (341-351)
Statut de publication:	Publié, 2007-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Bone alkaline phosphatase
	Clodronate
	Metastatic bone disease
	Serum C-terminal cross-linking telopeptide of type I collagen
	Urinary N-terminal cross-linking telopeptide of type I collagen
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0171-967X
	info:doi/10.1007/s00223-007-9061-x
	info:scp/35948993387
	info:pmid/17874331